Prosight Management

Prosight Management as of Dec. 31, 2024

Portfolio Holdings for Prosight Management

Prosight Management holds 36 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Galapagos Nv Spon Adr (GLPG) 7.8 $28M 1.0M 27.50
Acadia Healthcare (ACHC) 7.6 $27M 692k 39.65
Bridgebio Pharma (BBIO) 7.5 $27M 995k 27.44
Meiragtx Holdings (MGTX) 7.4 $27M 4.4M 6.09
Abcellera Biologics (ABCL) 6.0 $22M 7.4M 2.93
Adc Therapeutics Sa SHS (ADCT) 5.2 $19M 9.5M 1.99
Mirum Pharmaceuticals (MIRM) 5.2 $19M 451k 41.35
Icon SHS (ICLR) 4.9 $18M 85k 209.71
Roivant Sciences SHS (ROIV) 4.9 $18M 1.5M 11.83
Janux Therapeutics (JANX) 4.9 $18M 330k 53.54
Schrodinger (SDGR) 3.8 $14M 721k 19.29
Rocket Pharmaceuticals (RCKT) 3.8 $14M 1.1M 12.57
Zymeworks Del (ZYME) 3.3 $12M 820k 14.64
Kura Oncology (KURA) 3.2 $12M 1.3M 8.71
Amicus Therapeutics (FOLD) 2.4 $8.7M 920k 9.42
Zimmer Holdings (ZBH) 2.3 $8.5M 80k 105.63
Syndax Pharmaceuticals (SNDX) 2.3 $8.2M 620k 13.22
Shattuck Labs (STTK) 2.2 $8.0M 6.6M 1.21
Immunovant (IMVT) 2.1 $7.6M 306k 24.77
Blueprint Medicines (BPMC) 1.6 $5.8M 67k 87.22
Prothena Corp SHS (PRTA) 1.6 $5.8M 418k 13.85
Galapagos Nv Call Call Option 1.3 $4.9M 177k 27.50
Cytomx Therapeutics (CTMX) 1.1 $4.0M 3.9M 1.03
Haemonetics Corporation (HAE) 1.0 $3.6M 47k 78.08
Centene Corporation (CNC) 0.9 $3.3M 55k 60.58
Sight Sciences (SGHT) 0.9 $3.3M 909k 3.64
Livanova SHS (LIVN) 0.9 $3.2M 70k 46.31
Corbus Pharmaceuticals Hldgs Com New (CRBP) 0.9 $3.2M 270k 11.80
Erasca (ERAS) 0.7 $2.4M 947k 2.51
Spyre Therapeutics Com New (SYRE) 0.5 $1.9M 80k 23.28
Caredx (CDNA) 0.5 $1.7M 80k 21.41
Mural Oncology Pub Ord Shs (MURA) 0.4 $1.5M 467k 3.22
Fortrea Hldgs Common Stock (FTRE) 0.3 $1.0M 55k 18.65
Aileron Therapeutics Com New (RNTX) 0.3 $932k 405k 2.30
Immunome (IMNM) 0.2 $577k 54k 10.62
Onkure Therapeutics Com Cl A (OKUR) 0.2 $548k 64k 8.60